CN104623208A - Traditional Chinese medicine composition for treating pathogenic toxin internal exuberance type rubella - Google Patents
Traditional Chinese medicine composition for treating pathogenic toxin internal exuberance type rubella Download PDFInfo
- Publication number
- CN104623208A CN104623208A CN201510101997.4A CN201510101997A CN104623208A CN 104623208 A CN104623208 A CN 104623208A CN 201510101997 A CN201510101997 A CN 201510101997A CN 104623208 A CN104623208 A CN 104623208A
- Authority
- CN
- China
- Prior art keywords
- parts
- rubella
- chinese medicine
- medicine composition
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a traditional Chinese medicine composition for treating pathogenic toxin internal exuberance type rubella. The traditional Chinese medicine composition is prepared from campsis stem and leaf, red-spotted stonecrop, water pepper, Dioscorea collettii, tuber fleeceflower stem, Ludwigia octoualuis, dicranopteris pedata, myricaria bracteata royle, Siberian saltbush fruit, heath and liquorice. The traditional Chinese medicine composition can be clinically used for treating the pathogenic toxin internal exuberance type rubella.
Description
Technical field
The invention belongs to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine composition for the treatment of Sheng type rubella in evil poison.
Background technology
Rubella is the acute infectious disease caused by rubella virus.The traditional Chinese medical science is also called rubella or rubella.Previously, rubella outgoing is not too paid attention to, to its treatment, be only according to clinical manifestation, treat to the ill, without specific short.In recent years, the sickness rate of rubella rises to some extent, and is infectious because of it, and what can cause in various degree in certain condition and range is popular, and clinical companion sees that symptom is heavier, and serious have impact on the healthy of people.Spring, morbidity was more, Susceptible Age with 1-5 year in the majority, therefore be common in preschooler.Rubella clinical symptoms is slight, but after first trimester pregnancy primary infection rubella virus, virus enters fetus by blood tire barrier, often can cause congenital fetal anomaly, stillborn fetus, premature labor, therefore, and the making a definite diagnosis in early days and prevent very important of rubella.
Summary of the invention
The object of the present invention is to provide that a kind of therapeutic effect is good, effective percentage is high, Chinese medicine composition to Sheng type rubella in the evil poison of the treatment of human non-toxic's side effect.
The object of the present invention is achieved like this, according to Chinese medical theory, utilize the property of medicine of Chinese medicine uniqueness, adopt Caulis et Folium Campsis, Herba hylotelephii erythrosticti, Herba Polygoni hydropiperis, nine sons not from mother, Caulis Polygoni Multiflori, Ludwigia octovalvis (Jacq.) Raven root, wolf beanstalk grass, Weng Bo, Fructus Atriplicis Sibiricae, Photiniaserrulata, Radix Glycyrrhizae according to certain compatibility requirement, through being processed into.
Prepare Chinese medicine composition of the present invention to be made up of following raw material medicaments: Caulis et Folium Campsis 30-50 part, Herba hylotelephii erythrosticti 20-40 part, Herba Polygoni hydropiperis 20-40 part, nine sons are not from female 20-40 part, Caulis Polygoni Multiflori 10-30 part, Ludwigia octovalvis (Jacq.) Raven root 10-30 part, wolf beanstalk grass 10-30 part, Weng Bo 6-10 part, Fructus Atriplicis Sibiricae 6-10 part, Photiniaserrulata 6-10 part, Radix Glycyrrhizae 8-15 part.
Optimum weight part of traditional Chinese medicinal composition raw materials of the present invention is: Caulis et Folium Campsis 40 parts, Herba hylotelephii erythrosticti 30 parts, Herba Polygoni hydropiperis 30 parts, nine sons are not from mother 30 parts, Caulis Polygoni Multiflori 20 parts, Ludwigia octovalvis (Jacq.) Raven root 20 parts, wolf beanstalk grass 20 parts, Weng Bo 8 parts, Fructus Atriplicis Sibiricae 8 parts, Photiniaserrulata 8 parts, 12 parts, Radix Glycyrrhizae.
The pharmacological action of Chinese medicine of the present invention is as follows:
Caulis et Folium Campsis: bitter, flat.Heat clearing away, removing heat from blood, invigorates blood circulation.Cure mainly heat in blood itching over the body, rubella, sore throat, numb limbs and tense tendons, myopathy, traumatic injury.
Herba hylotelephii erythrosticti: bitter, sour, cold.GUIXIN, Liver Channel.Heat-clearing and toxic substances removing, promoting blood circulation and hemostasis.Cure mainly erysipelas, furuncle carbuncle furuncle, acute catarrhal conjunctivitis corneal nebula, dysphoria with smothery sensation mania and irritation, rubella, dermatitis rhus, burn and scald, snake bite and insect sting, spit blood, spitting of blood, menorrhagia, traumatic hemorrhage.
Herba Polygoni hydropiperis: pungent, bitter, flat.Return spleen, stomach, large intestine channel.The stagnant removing dampness of row, dissipating blood stasis stops blooding, dispelling wind for relieving itching, removing toxic substances.Cure mainly humidity hysteresis internal resistance, the vexed stomachache of gastral cavity, has loose bowels, dysentery, infantile malnutrition, metrorrhagia, amenorrhea due to stagnation of blood, dysmenorrhea, traumatic injury, and rheumatic arthralgia, has blood in stool, traumatic hemorrhage, skin pruritus, eczema, rubella, tinea pedis, carbuncle, venom.
Nine sons are not from mother: bitter, micro-pungent, are slightly cold.Expelling wind and removing dampness, removing obstruction in the collateral to relieve pain, heat-clearing and toxic substances removing.Cure mainly rheumatic arthralgia, contracture is numb, peratodynia, jaundice due to damp-heat, nebulousurine, drenches pain, leucorrhea, traumatic injury, eczema toxic swelling, rubella, eczema, venom.
Caulis Polygoni Multiflori: sweet, micro-hardship is flat.GUIXIN, Liver Channel.Tranquilizing by nourishing the heart, dispelling wind and removing obstruction in the collateral.Cure mainly insomnia, dreaminess, blood deficiency general pain, numbness of the skin, rheumatic arthralgia, rubella pruritus.
Ludwigia octovalvis (Jacq.) Raven root: light, bitter, cold.Heat-clearing and toxic substances removing, dampness removing, hemostasis.Cure mainly hematodiarrhoea, toothache, conjunctival congestion and swelling pain, hypertension, edema, stranguria, acute mastitis, skin ulcer swells, and damp and hot rash is itched.
Wolf beanstalk grass: bitter, sweet, flat.Stopping bleeding and knitting the fractured bone, clearing away heat-damp and promoting diuresis, removing toxic substances and promoting subsidence of swelling.Cure mainly metrorrhagia, epistaxis, hemoptysis, traumatic hemorrhage, injury and bone fracture, the puckery pain of pyretic stranguria, leucorrhea, rubella pruritus, skin ulcer swells, and scalds, hemorrhoid flaccidity, snake bite and insect sting, cough.
Weng Bo: sweet, temperature.Yang invigorating is dispersed, removing toxic substances rash, dispelling wind for relieving itching.Cure mainly measles without adequate eruption, high heat, cough, parotitis, rheumatic arthritis, rubella pruritus, ringworm, heat in blood alcoholism.
Fructus Atriplicis Sibiricae: bitter is flat.Dispel the wind, liver heat removing, improving eyesight, invigorates blood circulation.Cure mainly conjunctival congestion toxic swelling, completely, dizzy, rubella, skin pruritus, toxic swelling, galactostasis.
Photiniaserrulata: pungent, bitter, flat, mild toxicity.Return liver, kidney channel.Wind-damp dispelling, antipruritic, bone and muscle strengthening, liver and kidney tonifying.Cure mainly rheumatic arthralgia, wind syndrome of head is had a headache, rubella, flaccidity of feet and knees, lumbago due to renal deficiency, sexual impotence, seminal emission.
Radix Glycyrrhizae: sweet, flat.Enter spleen, stomach, the heart, lung meridian.With middle emergency, lung moistening, removing toxic substances, coordinating the actions of various ingredients in a prescription.Process with controlling weakness of the spleen and stomach, asthenia lack of appetite, stomachache loose stool, the anxious pain of extremity contraction, cardiopalmus, hysteria, consumptive lung disease is coughed; Raw with controlling laryngopharynx swelling and pain, carbuncle pyogenic infections from tumour or sore, infantile carbuncle, and medicine, alimentary toxicosis.
The traditional Chinese medical science is thought, rubella is by wind heat poison evil invasion and attack human body, violates and lung is defended, and then import edema caused by disorder of QI into, heat congesting in the lung, lung-heat is flourishing, injures lung network, caused by interior urgent nutrient blood and outgoing skin.Gently shallow from the beginning of the state of an illness, but be not sneezed at, once in pathogenic heat penetrate with, involve other internal organs, develop complications, then exacerbation of disease, treatment is then difficult.Caulis et Folium Campsis clearing away heat and cooling blood in the present invention is monarch drug; Herba hylotelephii erythrosticti heat-clearing and toxic substances removing, Herba Polygoni hydropiperis dispelling wind for relieving itching, nine sons, not from female expelling wind and removing dampness, are ministerial drug; Caulis Polygoni Multiflori dispelling wind and removing obstruction in the collateral, Ludwigia octovalvis (Jacq.) Raven root heat-clearing and toxic substances removing, wolf beanstalk grass is inducing diuresis and reducing edema, and Weng Bo detoxifies rash, Fructus Atriplicis Sibiricae expelling wind and activating blood circulation, Photiniaserrulata dispelling wind for relieving itching, Radix Glycyrrhizae invigorating the spleen and replenishing QI, coordinating the actions of various ingredients in a prescription.Find through clinical practice, have unique curative effect to Sheng type rubella in evil poison, effect of clearing heat for detumescence, dispelling wind for relieving itching, removing toxic substances rash played altogether by all medicines, reaches the object of Sheng type rubella in the evil poison for the treatment of.
Chinese medicine composition of the present invention is the routine patient of Sheng type rubella 128 in the evil poison of clinical observation in 2008 to 2012, and clinical report is as follows:
1, physical data
In 128 routine patients, women 76 example, male 52 example, minimum 2 years old of age, maximum 18 years old, disease time many in March to July, 11.2 years old mean age.
2, diagnostic criteria
Rubella spreads whole body after first going out face and becomes red grouper pimple, and with similar flu phenomenon, as the resistance of slight fever nose, sneeze, cough symptom, find the lymphadenectasis of neck side in inspection, the nearly bottleneck throat of oral cavity can see shinny pimple.And with following symptom: in heresy is imported into, dominance of heat in the interior, with high fever, thirsty, irritated, rash color is scarlet or secretly purple, and rash point is closeer, oliguria with reddish urine, constipation, red tongue, and yellow fur is rough, full and rapid pulse.Be diagnosed as Sheng type rubella in evil poison clinically.
3, Therapeutic Method:
3.1 prescriptions: Caulis et Folium Campsis 40g, Herba hylotelephii erythrosticti 30g, Herba Polygoni hydropiperis 30g, nine sons are not from female 30g, Caulis Polygoni Multiflori 20g, Ludwigia octovalvis (Jacq.) Raven root 20g, wolf beanstalk grass 20g, Weng Bo 8g, Fructus Atriplicis Sibiricae 8g, Photiniaserrulata 8g, Radix Glycyrrhizae 12g.
3.2 methods of preparation and use: said medicine routinely technique makes decoction, every day 1 dose, every day 1 time 3rd was 1 course for the treatment of.
4, therapeutic outcome:
4.1 criterion of cure: rash is checked and accepted not, and clinical symptoms all disappears, and laboratory examination is normal.
4.2 results: the routine patient of Sheng type rubella 128 in evil poison, all cure, cure rate 100%.
5, model case
5.1 Feng, female, 16 years old.Nearly 1 day fever and cough, body temperature 37.7 °, pharyngalgia, face is shown in a small amount of red grouper pimple, non-medication.Maculopapule rapid spread breast abdomen back after 3 days, rash color is scarlet, and rash point is closeer, red tongue, and yellow fur is rough, full and rapid pulse.Be diagnosed as Sheng type rubella in evil poison.Take medicine of the present invention, be decocted in water for oral dose, every day 1 dose, treat further consultation after 1 course for the treatment of, rash point disappears, and body is not itched, and body temperature is normal, recovery from illness.
5.2 Zhangs, man, 12 years old.Eruption 1 day, companion's nasal obstruction, watery nasal discharge, low grade fever is examined.Skin rash, rash color is purple dark, and rash point is intensive medium, gargalesthesia, and without cough, oliguria with reddish urine, defecates slightly dry, red tongue, full and rapid pulse.Be diagnosed as Sheng type rubella in evil poison.Take medicine of the present invention, be decocted in water for oral dose, every day 1 dose, treat further consultation after 1 course for the treatment of, transference cure, routine blood test and two is just normal, and rash point disappears, recovery from illness.
5.3 a surname certain, female, 8 years old.Cough in nearly 2 days, nasal obstruction, at first face is shown in a small amount of red rash, and rear erythra spreads whole body, and rash color is scarlet, and rash point is closeer, oliguria with reddish urine, constipation, red tongue, and yellow fur is rough.Be diagnosed as Sheng type rubella in evil poison.Take medicine of the present invention, every day 1 dose, after 1 course for the treatment of, Schultz-Charlton, two is just normal, recovery from illness.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further illustrated, and this embodiment following does not only limit the present invention for illustration of the present invention.
Embodiment 1, treating a Chinese medicine composition for Sheng type rubella in evil poison, is be not made up from female 20g, Caulis Polygoni Multiflori 10g, Ludwigia octovalvis (Jacq.) Raven root 10g, wolf beanstalk grass 10g, Weng Bo 6g, Fructus Atriplicis Sibiricae 6g, Photiniaserrulata 6g, Radix Glycyrrhizae 8g of Caulis et Folium Campsis 30g, Herba hylotelephii erythrosticti 20g, Herba Polygoni hydropiperis 20g, nine sons.
Embodiment 2, treating a Chinese medicine composition for Sheng type rubella in evil poison, is be not made up from female 30g, Caulis Polygoni Multiflori 20g, Ludwigia octovalvis (Jacq.) Raven root 20g, wolf beanstalk grass 20g, Weng Bo 8g, Fructus Atriplicis Sibiricae 8g, Photiniaserrulata 8g, Radix Glycyrrhizae 12g of Caulis et Folium Campsis 40g, Herba hylotelephii erythrosticti 30g, Herba Polygoni hydropiperis 30g, nine sons.
Embodiment 3, treating a Chinese medicine composition for Sheng type rubella in evil poison, is be not made up from female 40g, Caulis Polygoni Multiflori 30g, Ludwigia octovalvis (Jacq.) Raven root 30g, wolf beanstalk grass 30g, Weng Bo 10g, Fructus Atriplicis Sibiricae 10g, Photiniaserrulata 10g, Radix Glycyrrhizae 15g of Caulis et Folium Campsis 50g, Herba hylotelephii erythrosticti 40g, Herba Polygoni hydropiperis 40g, nine sons.
Claims (2)
1. treat a Chinese medicine composition for Sheng type rubella in evil poison, it is characterized in that it is made up of following raw material medicaments: Caulis et Folium Campsis 30-50 part, Herba hylotelephii erythrosticti 20-40 part, Herba Polygoni hydropiperis 20-40 part, nine sons are not from female 20-40 part, Caulis Polygoni Multiflori 10-30 part, Ludwigia octovalvis (Jacq.) Raven root 10-30 part, wolf beanstalk grass 10-30 part, Weng Bo 6-10 part, Fructus Atriplicis Sibiricae 6-10 part, Photiniaserrulata 6-10 part, Radix Glycyrrhizae 8-15 part.
2. Chinese medicine composition according to claim 1, is characterized in that it is made up of following raw material medicaments: Caulis et Folium Campsis 40 parts, Herba hylotelephii erythrosticti 30 parts, Herba Polygoni hydropiperis 30 parts, nine sons are not from mother 30 parts, Caulis Polygoni Multiflori 20 parts, Ludwigia octovalvis (Jacq.) Raven root 20 parts, wolf beanstalk grass 20 parts, Weng Bo 8 parts, Fructus Atriplicis Sibiricae 8 parts, Photiniaserrulata 8 parts, 12 parts, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510101997.4A CN104623208A (en) | 2015-03-09 | 2015-03-09 | Traditional Chinese medicine composition for treating pathogenic toxin internal exuberance type rubella |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510101997.4A CN104623208A (en) | 2015-03-09 | 2015-03-09 | Traditional Chinese medicine composition for treating pathogenic toxin internal exuberance type rubella |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104623208A true CN104623208A (en) | 2015-05-20 |
Family
ID=53202770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510101997.4A Pending CN104623208A (en) | 2015-03-09 | 2015-03-09 | Traditional Chinese medicine composition for treating pathogenic toxin internal exuberance type rubella |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104623208A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105126000A (en) * | 2015-09-10 | 2015-12-09 | 于国庆 | External ointment for treating infantile eczema |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030021857A1 (en) * | 2001-07-24 | 2003-01-30 | Nitto Denko Corporation | Composition having physiological activity and production method thereof |
| CN103142879A (en) * | 2013-03-19 | 2013-06-12 | 付传英 | Traditional Chinese medicine for treating rubella |
-
2015
- 2015-03-09 CN CN201510101997.4A patent/CN104623208A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030021857A1 (en) * | 2001-07-24 | 2003-01-30 | Nitto Denko Corporation | Composition having physiological activity and production method thereof |
| CN103142879A (en) * | 2013-03-19 | 2013-06-12 | 付传英 | Traditional Chinese medicine for treating rubella |
Non-Patent Citations (3)
| Title |
|---|
| 于作洋: "《儿科疾病》", 30 September 2007 * |
| 俞守义等: "《现代热带医学》", 31 August 2012 * |
| 冉先德: "《中华药海》", 31 August 1993 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105126000A (en) * | 2015-09-10 | 2015-12-09 | 于国庆 | External ointment for treating infantile eczema |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103393821B (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammation and preparation method thereof | |
| CN103142879B (en) | Traditional Chinese medicine for treating rubella | |
| CN102631512A (en) | Traditional Chinese medicine composition for curing chronic colitis | |
| CN103610915B (en) | Traditional Chinese medicine for treating swelling and pain in throat | |
| CN103830657A (en) | Medicine for treating chronic cholecystitis | |
| CN105727209A (en) | Traditional Chinese medicine composition for postpartum care | |
| CN103784806B (en) | A kind of Chinese medicine treating anemopyretic urticaria | |
| CN104623208A (en) | Traditional Chinese medicine composition for treating pathogenic toxin internal exuberance type rubella | |
| CN104740036A (en) | Traditional Chinese medicine composition for treating Qi stagnation and blood stasis amenorrhea | |
| CN104225569A (en) | Chinese medicinal composition for treating chronic enteritis | |
| CN103830679B (en) | A kind of medicine and application thereof for the treatment of irritable bowel syndrome | |
| CN102940739B (en) | Traditional Chinese medicine composition for treating vernal keratoconjunctivitis | |
| CN105106727A (en) | Traditional Chinese medicine composition for treating liver-fire attacking lung type hemoptysis | |
| CN105497267A (en) | Traditional Chinese medicine composition for treating extreme noxious heat type infantile jaundice | |
| CN105327299A (en) | Medicine for treating idiopathic thrombocytopenic purpura | |
| CN105663657A (en) | Decoction medicine capable of effectively treating fire excess from yin deficiency and preparation method thereof | |
| CN105343666A (en) | Traditional Chinese medicine for treating liver and spleen disharmony type ulcerative colitis | |
| CN104645233A (en) | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands | |
| CN104771498A (en) | Traditional Chinese medicine composition for treating mumps caused by accumulated toxic heat | |
| CN104547190A (en) | Traditional Chinese medicine for treating infantile jaundice | |
| CN104524331B (en) | Prevent the drug of mumps | |
| CN103977258A (en) | Traditional Chinese medicament for treating abdominal lump type pelvic inflammation | |
| CN109125528A (en) | A kind of Chinese medicine composition for treating ringworm of the body | |
| CN106822780A (en) | It is a kind of to treat the damp and hot Chinese medicine composition for stopping up resistance card of chronic prostatitis | |
| CN107441259A (en) | A kind of capsule medicine for treating rhinitis and nasosinusitis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150520 |